Traumagel, a plant-based hemostatic gel that controls bleeding in seconds when applied to a wound at the point of care, saw its commercial release in the United States.The commercialization was ...

Board of Directors has authorized Teleflex management to pursue a plan to separate the company’s Urology, Acute Care, and OEM ...

Good morning, ladies and gentlemen, and welcome to the Teleflex Fourth Quarter 2024 Earnings Conference Call. At this time all participants have been placed in a listen-only mode. At the end of the ...

Hemab Therapeutics, a clinical-stage biotechnology company developing novel prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders, today announced the first participant ...

A ribbon-cutting ceremony was held to officially open the new Fibroline USA Innovation Lab housed at the Navis TubeTex ...

The global biosurgery market is projected to grow at a CAGR of 5% from 2025 to 2030. This growth is driven by the increasing ...

In recent years, neurosurgery has undergone transformative changes with cutting-edge technologies redefining treatment ...

Bin Liu, PhD, associate professor at The Hormel Institute, University of Minnesota, is among the authors of a newly published paper appearing in the leading scientific journal Nature, entitled ...

【SCUM人渣】是一款开放世界生存动作游戏，本次为您带来各种智力强化物品的代码，如碎布 :#Spawnitem Rags、止血敷料:#SpawnItem Hemostatic_Dressing、胶囊碘化钾药片： #SpawnItem ...

Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, is hosting an R&D Day today in New York City and will also webcast the event. The Company plans to showcase its R&D progress and ...

The field of transfusion medicine has long sought effective alternatives to human blood, focusing increasingly on bio-synthetic blood substitutes and ...